Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiran Gupta

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Health and Social Care Delivery Research|June 16, 2025
Barriers to and outcomes of unspecified kidney donation in the UK: BOUnD, a mixed-methods studyNizam Mamode, Sam Norton, Paul McCrone, et al.
Radiation Research|April 7, 2011
Iron-ion radiation accelerates atherosclerosis in apolipoprotein E-deficient miceTao Yu, Brian W Parks, Shaohua Yu, et al.
Plos One|January 27, 2018
Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approachXiaoyan Li, Allison Keshishian, Melissa Hamilton, et al.
Thrombosis and Haemostasis|March 17, 2017
Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice. A propensity-matched analysis of 76,940 patientsXiaoyan Shawn Li, Steve Deitelzweig, Allison Keshishian, et al.
Stroke|December 21, 2018
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation PatientsGregory Y H Lip, Allison Keshishian, Xiaoyan Li, et al.
The American Journal of Medicine|August 11, 2020
Corrigendum to "Effectiveness and Safety of Oral Anticoagulants in Adults with Non-valvular Atrial Fibrillation Patients and Concomitant Coronary/Peripheral Artery Disease" American Journal of Medicine 131:09 (2018): 1074-1085.e4Renato D Lopes, Jan Steffel, Manuela Di Fusco, et al.
The American Journal of Medicine|May 29, 2018
Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery DiseaseRenato D Lopes, Jan Steffel, Manuela Di Fusco, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Health and Social Care Delivery Research|June 16, 2025
Barriers to and outcomes of unspecified kidney donation in the UK: BOUnD, a mixed-methods studyNizam Mamode, Sam Norton, Paul McCrone, et al.
Radiation Research|April 7, 2011
Iron-ion radiation accelerates atherosclerosis in apolipoprotein E-deficient miceTao Yu, Brian W Parks, Shaohua Yu, et al.
Plos One|January 27, 2018
Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approachXiaoyan Li, Allison Keshishian, Melissa Hamilton, et al.
Thrombosis and Haemostasis|March 17, 2017
Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice. A propensity-matched analysis of 76,940 patientsXiaoyan Shawn Li, Steve Deitelzweig, Allison Keshishian, et al.
Stroke|December 21, 2018
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation PatientsGregory Y H Lip, Allison Keshishian, Xiaoyan Li, et al.
The American Journal of Medicine|August 11, 2020
Corrigendum to "Effectiveness and Safety of Oral Anticoagulants in Adults with Non-valvular Atrial Fibrillation Patients and Concomitant Coronary/Peripheral Artery Disease" American Journal of Medicine 131:09 (2018): 1074-1085.e4Renato D Lopes, Jan Steffel, Manuela Di Fusco, et al.
The American Journal of Medicine|May 29, 2018
Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery DiseaseRenato D Lopes, Jan Steffel, Manuela Di Fusco, et al.
Pageof 5